Literature DB >> 1672311

A case of clozapine-induced neuroleptic malignant syndrome.

D D Miller1, M J Sharafuddin, R G Kathol.   

Abstract

The treatment of psychotic symptoms in patients with a previous history of neuroleptic malignant syndrome (NMS) remains a dilemma. The authors describe a case in which clozapine caused NMS in a schizophrenic man who had previously experienced NMS during treatment with various antipsychotics. To their knowledge, this is the first report of "classical" NMS caused by clozapine alone.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1672311

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  6 in total

Review 1.  Clinical profile of clozapine: adverse reactions and agranulocytosis.

Authors:  J A Lieberman; A Z Safferman
Journal:  Psychiatr Q       Date:  1992

Review 2.  Tolerability of atypical antipsychotics.

Authors:  C Stanniland; D Taylor
Journal:  Drug Saf       Date:  2000-03       Impact factor: 5.606

Review 3.  When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature.

Authors:  Peter Manu; Deepak Sarpal; Owen Muir; John M Kane; Christoph U Correll
Journal:  Schizophr Res       Date:  2011-11-22       Impact factor: 4.939

Review 4.  Adverse effects of antipsychotic drugs.

Authors:  A K Malhotra; R E Litman; D Pickar
Journal:  Drug Saf       Date:  1993-12       Impact factor: 5.606

5.  Neuroleptic malignant syndrome and lithium carbonate.

Authors:  S Fava; A C Galizia
Journal:  J Psychiatry Neurosci       Date:  1995-07       Impact factor: 6.186

6.  MRI white matter hyperintensity in neuroleptic malignant syndrome (NMS)--a clue to pathogenesis?

Authors:  T Becker; J Kornhuber; E Hofmann; M Weller; C Rupprecht; H Beckmann
Journal:  J Neural Transm Gen Sect       Date:  1992
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.